InsidersTradesSigma
Discover the full record of transactions filed by Iris Loew-Friedrich, Director. Insider active across 2 companies, notably Swedish Orphan Biovitrum AB (publ). Aggregated, 1 reports have been published. The latest transaction was filed on 10 February 2026 — Purchase. Regulator: FIN-FSA. The full history is openly available.
1 of 1 declaration
Iris Loew-Friedrich is a board member of Swedish Orphan Biovitrum AB. In this role, she participates in strategic discussions and decision-making within the board. Iris brings expertise in the pharmaceutical sector, thus contributing to the strategic direction of the company. Her commitment to ethics and accountability is an asset for Swedish Orphan Biovitrum.